Peptech Animal Health

Peptech Animal Health is a biotechnology company specializing in the development and manufacture of peptide-based veterinary pharmaceuticals and advanced drug delivery systems. Originally a subsidiary of Peptech Limited, the company was divested to Parma Corporation in 2008 and subsequently acquired by Virbac in 2011. It is best known for its proprietary slow-release subcutaneous implant technology, which is utilized in its flagship products Suprelorin, for reversible contraception in dogs, and Ovuplant, for equine ovulation induction. The company operates a specialized GMP manufacturing facility in Australia and remains a key provider of innovative reproductive management solutions for the global animal health market.